Vitamin D and drug-metabolising enzymes
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Experimental studies on the molecular regulation of human drug metabolism have revealed that vitamin D up-regulates transcription of several key enzymes, such as CYP3A4, through the vitamin D receptor pathway in intestinal and hepatic cells. Recent data suggest that this results in seasonal changes with higher clearance of orally administered drugs during periods with high UV-B radiation and vitamin D levels. Taken together, vitamin D status might contribute to inter- and intraindividual differences in drug metabolism, but the therapeutic impact of these findings remains to be established.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RXR can heterodimerize with more NRs, such as pregnane X receptor (PXR), constitutive androstane receptor (CAR) and vitamin D receptor (VDR), among others [147,162].”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [162]
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
WEBB, A. R., KLINE, L., & HOLICK, M. F. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-2-373 · Cited by 1,659
Genome-wide association study of circulating vitamin D levels
Ahn, J., Yu, K., Stolzenberg-Solomon, R., Simon, K. C., McCullough, M. L., Gallicchio, L., Jacobs, E. J., Ascherio, A., Helzlsouer, K., Jacobs, K. B., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq155 · Cited by 810
Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 789
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
Cheng, J. B., Levine, M. A., Bell, N. H., Mangelsdorf, D. J., & Russell, D. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402490101 · Cited by 762
Enzymes involved in the activation and inactivation of vitamin D
PROSSER, D., & JONES, G. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.10.005 · Cited by 658
Wang, T.-T., Tavera-Mendoza, L. E., Laperriere, D., Libby, E., Burton MacLeod, N., Nagai, Y., Bourdeau, V., Konstorum, A., Lallemant, B., Zhang, R., et al. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0106 · Cited by 575
Two nuclear signalling pathways for vitamin D
Carlberg, C., Bendik, I., Wyss, A., Meier, E., Sturzenbecker, L. J., Grippo, J. F., & Hunziker, W. (1993) · Nature · doi:10.1038/361657a0 · Cited by 552
The vitamin D story: a collaborative effort of basic science and clinical medicine 1
Deluca, H. F. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.3.3280376 · Cited by 534
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.
Kolars, J. C., Schmiedlin-Ren, P., Schuetz, J. D., Fang, C., & Watkins, P. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116064 · Cited by 528
Cited by
Carazo, A., Macáková, K., Matoušová, K., Krčmová, L. K., Protti, M., & Mladěnka, P. (2021) · Nutrients · doi:10.3390/nu13051703 · Cited by 461
Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms
Muñoz, A., & Grant, W. B. (2022) · Nutrients · doi:10.3390/nu14071448 · Cited by 234
“This may have a positive effect on the prevention of tumorigenesis and perhaps another more controversial impact on the inactivation of chemotherapeutic drugs [298].”
BackgroundRole of vitamin D receptor in the regulation of CYP3A gene expression
Qin, X., & Wang, X. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.03.005 · Cited by 75
Datta, P., Philipsen, P. A., Olsen, P., Bogh, M. K. B., Johansen, P., Schmedes, A., Morling, N., & Wulf, H. C. (2017) · Photochemical & Photobiological Sciences · doi:10.1039/c6pp00258g · Cited by 48
Vitamin paradox in obesity: Deficiency or excess?
Zhou, S., Li, D., Chen, N.-N., & Zhou, Y. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i10.1158 · Cited by 46
Intake of ergosterol increases the vitamin D concentrations in serum and liver of mice
Baur, A. C., Kühn, J., Brandsch, C., Hirche, F., & Stangl, G. I. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105435 · Cited by 23
Riccardi, C., Perrone, L., Napolitano, F., Sampaolo, S., & Melone, M. A. B. (2020) · Cancers · doi:10.3390/cancers12102965 · Cited by 23
Björkhem‐Bergman, L., Nylén, H., Norlin, A.-C., Lindh, J. D., Ekström, L., Eliasson, E., Bergman, P., & Diczfalusy, U. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.051136 · Cited by 18
“The heterodimer complex binds to vitamin D response elements in promoters of several genes, including CYP3A4 (Lindh et al., 2012).”
BackgroundSelf-citationLancia, P., de Beaumais, T. A., Élie, V., Garaix, F., Fila, M., Nobili, F., Ranchin, B., Testevuide, P., Ulinski, T., Zhao, W., et al. (2018) · Pediatric Nephrology · doi:10.1007/s00467-017-3881-3 · Cited by 17
Molecular evidence of role of vitamin D deficiency in various extraskeletal diseases
Zendehdel, A., & Arefi, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28185 · Cited by 21
Effects of vitamin D on drugs: Response and disposal
Peng, J., Liu, Y., Xie, J., Yang, G., & Huang, Z. (2020) · Nutrition · doi:10.1016/j.nut.2020.110734 · Cited by 18
Cusato, J., Bertani, L., Antonucci, M., Tomasello, C., Caviglia, G. P., Dibitetto, S., Massano, A., Mangia, M., Mula, J., Ceccarelli, L., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14121230 · Cited by 13
“Through its receptor VDR, VD modulates the expression of genes encoding transporters and enzymes responsible for drug transport and metabolism, such as cytochromes (CYPs) [22].”
Cusato, J., Tempestilli, M., Calcagno, A., Vergori, A., Piselli, P., Antonucci, M., Avataneo, V., Palermiti, A., Notari, S., Antinori, A., et al. (2021) · Nutrients · doi:10.3390/nu13103571 · Cited by 8
“In fact, 24-hydroxylases and other CYPs resulted in being upregulated in the presence of PXR. Studies reported that in vitro HIV protease inhibitors, particularly ritonavir, inhibit the conversion of 25(OH)D3 to 1,25(OH)D3 and 1,25(OH)D3 degradation [17].”
BackgroundInfluentialVitamin D: an important treatment for secondary hyperparathyroidism in chronic kidney disease?
Yu, J., Li, Y., Zhu, B., Shen, J., & Miao, L. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-04334-9 · Cited by 9
“The vitamin’s two main forms are D 2 (ergo-calciferol) and D 3 (cholecalciferol) [10–12].”
Bergström, H., Frankling, M. H., Klasson, C., Lövgren‐Sandblom, A., Diczfalusy, U., & Björkhem‐Bergman, L. (2021) · Cancers · doi:10.3390/cancers13184689 · Cited by 3
“However, results have been discordant [14,15].”
BackgroundSelf-citationCusato, J., Mula, J., Palermiti, A., Manca, A., Antonucci, M., Avataneo, V., Vivo, E. D. D., Ianniello, A., Calcagno, A., Perri, G. D., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091202 · Cited by 3
“In fact, they showed that tacrolimus and sirolimus immunosuppressive agent concentrations decreased with increased VD levels; this could be due to a VD inductive effect on genes encoding for proteins involved in these drugs’ metabolism and excretion (CYP3A5, CYP2B6 and ABCB1 genes encoding for CYP3A5, CYP2B6 enzymes a…”
BackgroundPrevalence of vitamin D deficiency in Libya and its relation to other health disorders
Younis, M. Y. G. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.36 · Cited by 9
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants
Cusato, J., Palermiti, A., Manca, A., Mula, J., Antonucci, M., Nicolò, A. D., Allegra, S., Francia, S. D., Chiara, F., Perri, G. D., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15050630 · Cited by 1
“VD modulates the enzymes involved in drug metabolism and elimination through a classic activation of VD receptor (VDR)-mediated gene transcription [9].”
BackgroundCruz, A. A., de Moura, J. P., & Dantas, R. P. S. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.5281/zenodo.4361676
Dermatoloji ve Kozmetolojide D Vitamini
Cenk, H., Rüstemoğlu, A., Akbulut, S., Uzdoğan, A., Yücel, Ç., Çifci, A., Yakut, H. İ., Oğuz, I. D., Türkmen, D., Demirbaş, A., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1313 · Cited by 1
Palermiti, A., Manca, A., Mastrantonio, F., Maiese, D., Genova, E. C., Menegatti, G., Simiele, M., Martino, C., Nicolò, A. D., & D’Avolio, A. (2025) · Molecules · doi:10.3390/molecules31010130
“…to the role of VD in recent years, with indications emerging that, aside from its role in bone and calcium homeostasis, VD supplementation may act as an immunomodulatory agent [34–36] with a number of actions on gene expression and an impact on drug metabolism and plasma concentrations [37–39].”
Variabilité des effets des médicaments en transplantation pédiatrique : impact pharmacogénétique
Lancia, P. (2017) · theses.fr (ABES) · doi:10.70675/b9df057ezdccaz4525zabbcz8474ce5fdf81
Metadata
- Authors
- Lindh, J. D., Björkhem-Bergman, L., & Eliasson, E.
- Affiliations
- Karolinska University Hospital (SE)
- Corresponding author
- Eliasson, Erik
- Venue
- Photochemical & Photobiological Sciences
- Published
- 2012-12
- Volume
- 11
- Issue
- 12
- Pages
- 1797-1801
- ISSN
- 1474-905X (ISSN-L)
- 1474-9092
- OpenAlex
- W2039277970
- Cited by
- 22
- References
- 43
- Citations by year
- 2025: 1 · 2024: 2 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 2 · 2015: 1 · 2013: 1
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Photochemical & Photobiological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Karolinska Institutet
- Stockholms Läns Landsting
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- vitamin D, drug-metabolizing enzymes, CYP3A4, vitamin D receptor, transcriptional regulation, seasonal variation, UV-B radiation, drug clearance, interindividual variability, within-person variability, intestinal cells, hepatocytes
- MeSH terms
- Pharmaceutical Preparations, Half-Life, Humans, Inactivation, Metabolic, Ultraviolet Rays, Vitamin D, Tacrolimus, Cyclosporine, Receptors, Calcitriol, Caco-2 Cells, Sirolimus, Cytochrome P-450 CYP3A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.